HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Cytomegalovirus infection in HIV].

Abstract
The data are taken from a retrospective study of 24 patients with AIDS who developed CMV disease. This study was performed to detect the principal characteristics associated with the development of CMV disease. Age, sex, risk factors, the time interval between HIV seropositivity to CMV disease were examined, as well as efficacy of gancyclovir therapy in both groups of patients with symptomatic and asymptomatic retinitis. When the chorioretinitis is still asymptomatic the early treatment of CMV disease may suppress progression of retinic lesions and seems to be efficacious to prevent the evolution of CMV disease.
AuthorsU Ferone, C Cerimele, L Isceri, V Trinchieri, F Proietti, V Galati, M Monacelli
JournalRivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques (Riv Eur Sci Med Farmacol) 1994 May-Aug Vol. 16 Issue 3-4 Pg. 55-60 ISSN: 0392-291X [Print] Italy
Vernacular TitleIl citomegalovirus nell'infezione da HIV.
PMID7480960 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Antiviral Agents
  • Ganciclovir
Topics
  • AIDS-Related Opportunistic Infections (drug therapy)
  • Acquired Immunodeficiency Syndrome (complications, drug therapy)
  • Adult
  • Antiviral Agents (therapeutic use)
  • Cytomegalovirus Retinitis (drug therapy, etiology)
  • Female
  • Ganciclovir (therapeutic use)
  • HIV-1
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: